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Abstract: Multidrug resistant microorganisms are forecast to become the single biggest challenge
to medical care in the 21st century. Over the last decades, members of the genus Acinetobacter have
emerged as bacterial opportunistic pathogens, in particular as challenging nosocomial pathogens
because of the rapid evolution of antimicrobial resistances. Although we lack fundamental biological
insight into virulence mechanisms, an increasing number of researchers are working to identify
virulence factors and to study antibiotic resistance. Here, we review current knowledge regarding
the regulation of virulence genes and antibiotic resistance in Acinetobacter baumannii. A survey of
the two-component systems AdeRS, BaeSR, GacSA and PmrAB explains how each contributes to
antibiotic resistance and virulence gene expression, while BfmRS regulates cell envelope structures
important for pathogen persistence. A. baumannii uses the transcription factors Fur and Zur to sense
iron or zinc depletion and upregulate genes for metal scavenging as a critical survival tool in an animal
host. Quorum sensing, nucleoid-associated proteins, and non-classical transcription factors such as
AtfA and small regulatory RNAs are discussed in the context of virulence and antibiotic resistance.
Keywords: Acinetobacter baumannii; virulence gene regulation; two-component systems; multidrug
efflux pumps; metal acquisition; antibiotic resistance
1. Introduction
Bacterial infections are a leading cause of death worldwide, and the fading age of antibiotics
increases risks associated with basic healthcare and surgeries. Moreover, the continuous emergence
of multidrug resistant (MDR) microorganisms is a major economic burden, yet the development of
new antimicrobials has stalled [1,2]. The most prominent MDR bacterial genera currently evading
antimicrobial treatment and spreading worldwide as nosocomial pathogens have been dubbed the
ESKAPE organisms [2–4]: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter
baumannii, Pseudomonas aeruginosa and Enterobacter species. Notably, infections caused by the
Gram-negative coccobacillus Acinetobacter baumannii are growing in number in hospitals around
the world [5–9]. The genus Acinetobacter belongs to the class Gamma-proteobacteria, the order
Pseudomonadales, and the family Moraxellaceae. Only a few members of this genus have a history
of infecting humans, of which A. baumannii, A. pittii and A. nosocomialis are the most clinically
relevant [10,11], while many other Acinetobacter species are non-pathogenic. Infections of humans are
mostly, but not exclusively, hospital-acquired. Community-acquired infection with A. baumannii is rare
and often occurs in predisposed individuals, mostly in tropical regions [12]. Predisposing factors may
include diabetes, chronic lung conditions or post-trauma and adverse lifestyles, such as alcohol abuse
and smoking [13].
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In the United States, A. baumannii is now responsible for more than 10% of nosocomial
infections [14]. Critically ill patients, including intensive care unit patients, are at a particularly high risk
of infection by A. baumannii. The bacterium causes a variety of diseases such as ventilator-associated
pneumonia (VAP), bacteraemia, skin and soft tissue infections, endocarditis, urinary tract infections
and meningitis [6,10]. The mortality rate in patients is debated, but it can reach up to 35% or even
higher [7,15] and likely depends on a patient’s individual condition and the A. baumannii strain.
Carbapenem-resistant A. baumannii (CRAB) strains in particular have emerged as one of the most
concerning antibiotic-resistant pathogens [16]. Based on recent estimates, over 50% of A. baumannii
isolates from intensive care units are carbapenem-resistant, and therapy of CRAB infections is estimated
to cost global healthcare systems in excess of 742 million US Dollars annually [17]. Of particular
concern is the isolation of pan-resistant A. baumannii strains across the world, illustrating the ongoing
emergence of increasingly dangerous isolates [18–23].
To successfully combat the spread of MDR bacterial pathogens, we must develop sufficient
biological understanding to engineer new and effective interventions. Despite the growing clinical
importance of pathogenic strains of A. baumannii, the scientific community has only begun to
understand the fundamentals of A. baumannii infection biology. A number of studies have identified
virulence factors, from extracellular matrices and biofilm formation to drug efflux pumps. For example,
the impact of cell surface-associated virulence factors and secretion systems on cell–host interaction
has been reviewed recently [24].
A next step is to understand the mechanisms that control expression of virulence factors, because
bacteria must carefully control gene expression to ensure correct spatiotemporal production. Regulated
expression integrates virulence factors into cellular physiology and reflects how the pathogen is sensing
and interacting with host-associated environments and other niches. To combat antibiotic resistance
and develop knowledge-based interventions, detailed understanding of the resistance mechanisms
and the regulation of genes conferring drug resistance are required. In this review, we provide an
overview of current knowledge of the protein and RNA transcription factors that control virulence
gene expression and antibiotic resistance in A. baumannii, followed by a brief discussion of research
horizons that promise important insights into A. baumannii virulence.
2. Two-Component Systems
Two-component systems (TCS) are ubiquitous systems of signal transduction in bacteria [25].
A typical TCS is composed of a sensor kinase embedded in the cytoplasmic membrane that is able
to sense and respond to extracellular and/or intracellular features, like osmotic pressure or pH [26].
When triggered by the environmental or physiological stimulus, the sensor kinase relays this signal by
phosphorylating a cognate response regulator. The response regulator is a transcription factor that
undergoes a conformational change upon phosphorylation that facilitates (or in some cases hinders)
DNA-binding. Using adenosine triphosphate (ATP), the sensor kinases autophosphorylates at a
histidine residue which can be transferred onto an aspartic acid residue of the response regulator,
usually leading to a transcriptional response (activation and/or repression). When the stimulus ceases,
the phosphorelay system runs in reverse wherein the sensor kinase dephosphorylates the response
regulator and reverses the transcriptional response.
Although TCS can be highly conserved between species, the regulons they control can differ even
among closely related species [27,28]. Also emerging is an appreciation that both the phosphorylated
and unphosphorylated forms of the response regulator can control different regulons. An example is
the SsrB protein in Salmonella, which activates virulence genes as phosphorylated form and biofilm
formation in an unphosphorylated state [29,30]. In A. baumannii AB5075-UW, 10 sensor kinases
and 17 response regulators are annotated [31]. This is an average number of response regulators
for pathogenic bacteria, but lower than the average of 40 in Escherichia coli and around 90 in the
more closely related Pseudomonas [32]. The excess of response regulators highlights the potential for
cross-talk among TCS. Five TCS have been studied in Acinetobacter (Table 1), and a simple schematic of
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the regulators and their virulence gene targets is provided in Figure 1. Of these, four TCS are conserved
in 15 sequenced A. baumannii and one A. baylyi genomes provided at the Prokaryotic Genome Analysis
Tool webserver (http://tools.uwgenomics.org/pgat/) [33], whereas adeRS is missing from A. baumannii
SDF and A. baylyi ADP1.
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Figure 1. Overview of the impact of five cinetobacter baumannii two-component systems on gene
expression of selected genomic loci. LPS: lipopolysaccharide.
2.1. AdeRS
The adeRS TCS is the best characterized regulatory system in A. baumannii. Most notably, it controls
the expression of the RND-type efflux pump AdeABC [34,35]. Deletion of adeR or adeS led to increased
susceptibility towards aminoglycosides [35]. Many studies have connected antibiotic resistance to
increased production of AdeABC, e.g., resistance to tigecycline, fluoroquinolones, aminoglycosides
and others [36,37]. Decreased susceptibility was reported to be caused by mutations in adeRS which
led to overexpression of adeABC [38–41]. Moreover, adeRS shows a high level of sequence variation
in clinical isolates which could explain the differences in tigecycline resistance [42]. The regulation
of adeABC is complex and not only controlled by AdeRS, as verexpression of the efflux pump
was also ob erved in a strain lacking insertion mutations in adeRS that cause ov rexpression of the
syste [43]. The overexpression of AdeABC led to virulence in a pulmonary infection model,
which suggest th t increased levels of AdeABC are b neficial to both antibio ic resistance and i vivo
fitne s, and can explain why adeRS mutations are frequently bserve in cli ical isolates [43–46].
However, the AdeRS regulon includes many other genes that contrib te to virulence as recently
reported using RNA-seq [47]. It was found that AdeRS directly or indirectly regulates 579 genes,
most notably those involved in the expression of efflux pumps, biofilm formation and virulence in a
Galleria mellonella larvae infection model. Intriguingly, some outcomes of the AdeRS deletion appeared
to be strain specific. Deletion of adeRS in A. baumannii AYE resulted in loss of biofilm formation
in an ex vivo porcine vaginal mucosa model and a reduced host epithelial cell toxicity, but not in
A. baumannii S1 [47]. Strain to strain variation in a key feature such as antimicrobial resistance highlights
the difficulty of extrapolating a significant biological finding between strains [42,48]. This diversity
among A. baumannii strains makes treatment even more challenging [49].
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2.2. BaeSR
The baeSR TCS in Acinetobacter spp. was so named because the nucleotide sequence indicated
high similarity to baeSR in E. coli and to Salmonella enterica serovar Typhimurium [50]. Among other
genes, BaeSR controls drug efflux pumps in E. coli, which suggested a similar function for A. baumannii.
Indeed, deletion of baeSR led to significantly reduced expression of the major efflux pumps AdeABC,
AdeIJK, and MacAB-TolC, resulting in increased susceptibility to tigecycline [50,51]. The regulation
of the three efflux pumps is proposed to be indirect, though, as purified BaeR-His did not bind the
promoters of adeA, adeI or macA in electrophoretic mobility shift assays. However, it was unclear
whether the phosphorylation state of purified BaeR-His was appropriate for DNA binding, or whether
the histidine tag might interfere with DNA binding. As the regulons of AdeRS and BaeSR overlap,
this could also mean that BaeSR functions through cross-talk with AdeRS. The expression of baeSR
increased upon growth in elevated sucrose levels, suggesting that BaeS responds to changes in osmotic
pressure [50]. In addition, tannic acid which showed potential as an antibiotic adjuvant [52,53],
increased gene expression of the three efflux pumps mentioned above [51].
2.3. BfmRS
The ability to form biofilms on abiotic surfaces allows A. baumannii to resist adverse conditions,
such as desiccation or detergents. Protein filaments called pili are required for attachment to surfaces.
In A. baumannii, the best studied pili involved in biofilm formation are produced by the csuA/BABCDE
usher-chaperone assembly system, which is regulated by the TCS termed bfmRS [54,55]. Deletion of
only the response regulator bfmR resulted in complete loss of biofilm formation on plastic, while a bfmS
sensor kinase mutant retained some ability to from biofilm, suggesting that BfmR can be activated by
alternate sensor kinases [54]. Whether csuA/BABCDE is required for attachment to host tissues is not
fully resolved. csuA/BABCDE is not involved in adherence to bronchial epithelial cells [56], but deletion
of the sensor kinase bfmS led a loss of adhesion to A549 human alveolar epithelial cells [57]. However,
adhesion to A549 could be independent of csuA/BABCDE, if BfmRS controls the regulation of other
adhesion factors.
BfmRS both enhances and represses antibiotic resistance. Deletion of bfmS led to an increased
minimum inhibitory concentration (MIC) of ciprofloxacin and a decreased MIC of imipenem, while
deletion of bfmR increased the MIC of meropenem and colistin [58]. Moreover, outer membrane
proteins, such as the major virulence factor OmpA, were increasingly released into the supernatant,
indicating that cellular integrity is compromised. Indeed, BfmRS regulates genes that maintain cellular
morphology and control cell division—the direct targets are however unknown [54]. Recently, BfmRS
was shown to control gene expression of the K locus, a major virulence determinant in A. baumannii
ATCC17978, which harbors genes for exopolysaccharide (e.g., capsule) production [59]. Surprisingly,
capsule synthesis was not affected in deletions of bfmR in two clinical isolates that showed reduced
growth/survival in human ascites’ fluid and serum [58]. These diverse phenotypes highlight the
multifaceted nature of the BfmRS regulon. Unfortunately, we lack a detailed understanding of the
regulon in biofilm-inducing conditions, in an infection model, or a description of strain-specific
differences in regulon membership. As BfmR was recently suggested as a candidate drug target,
deeper knowledge of the regulon of the BfmRS TCS is therefore of particular interest [58].
2.4. GacSA
The GacS sensor kinase was identified through its mutagenesis in a transposon screen of
A. baumannii ATCC19606; the mutant was unable to use citrate as a sole carbon source [60] and
to kill the human fungal pathogen Candida albicans [61]. Today, the gacSA TCS is established as a
global regulator in A. baumannii controlling the expression of 674 genes including virulence genes,
biofilm and pili formation, resistance against human serum, motility, and metabolism of aromatic
compounds [62,63]. Deletion of GacS led to an avirulent phenotype in a mouse septicaemia model
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and greatly reduced bacterial load in spleen, kidney and liver 12 hours after infection, highlighting
the importance of GacS during systemic infection. Intriguingly, GacS controls a catabolic pathway of
aromatic compounds (termed paa, phenylactetic acid pathway) that was shown to be important for full
virulence. Genome comparisons revealed that the A. baumannii paa operon is similar to the well-studied
paa system in E. coli [62,64]. The aromatic compounds phenylacetate and phenylalanine are converted
into acetyl- and succinyl-CoA and fed into the tricarboxylic acid cycle. Surprisingly, inhibition of the
paa pathway led to increased killing of A. baumannii in a zebrafish infection model. The metabolic
by-product phenylacetate accumulates in the gacS mutant and represents a potent chemoattractant
for neutrophils, thus GacS is involved in innate immune evasion by controlling the expression of the
paa locus [63]. The GacSA TCS is not a contiguous operon as each gene is located far apart on the
chromosome, unlike the AdeRS, BaeSR, PmrAB and BfmRS TCS in A. baumannii. Whereas GacS is
alone in a transcriptional unit, the response regulator GacA does lie adjacent to another sensor kinase
of unknown function (A1S_0235 in A. baumannii ATCC17978), suggesting that GacS has co-opted a
response regulator to create cross-talk between two TCS.
Table 1. Best characterized regulatory systems in Acinetobacter baumannii.
Gene
Name Type Function and Phenotype
Relevant
References
adeRS Two-component system
Directly or indirectly controls 579 genes. Regulates the expression
of the AdeABC drug efflux pump. Required for
biofilm formation biofilm.
[35,47]
bfmRS Two-component system
Controls the expression of the K locus (exopolysaccharide
production/capsule). Regulates expression of CsuA/BABCDE
chaperone-usher secretion system, biofilm formation on
abiotic surfaces.
[54,58,59]
gacSA Two-component system
Directly or indirectly controls 674 genes, including virulence
genes, biofilm and pili formation, resistance against human serum,
motility, and metabolism of aromatic compounds (paa locus).
[60,62,63]
baeSR Two-component system
Deletion results in reduced expression of AdeABC, AdeIJK,
MacAB-TolC drug efflux pumps and increases susceptibility to
tannic acid.
[50,51]
pmrAB Two-component system Mutations in pmrAB can confer resistance to colistin. [65]
fur Transcription factor Transcriptional repressor of genes involved in iron homeostasis. [66]
zur Transcription factor Transcriptional repressor of genes involved in zinc homeostasis. [67,68]
abaR Transcription factor AHL-responsive transcription factor involved in quorum sensingand biofilm formation. [69,70]
atfA RNA polymerasebinding protein
Deletion of atfA results in cell enlargement, loss of biofilm
formation and increased susceptibility to antibiotics and ethanol. [71]
hns Nucleoid-associatedprotein
Deletion results in a hyper-motile phenotype, enhanced
adherence to human pneumocytes and enhanced virulence in a
nematode infection assay.
[72,73]
2.5. PmrAB
In response to the increasing drug resistance of A. baumannii, including resistance to
fluoroquinolones and carbapenems, the cationic peptide antibiotic colistin (polymyxin E) has become a
last line of defence to treat infections with MDR A. baumannii strains [74,75]. However, colistin-resistant
strains have emerged and one mechanism of resistance is mediated by mutations in the TCS encoded
by pmrAB (polymyxin resistance) [76,77]. Indeed, PmrAB has been implicated in polymyxin B and
colistin resistance in several other species, such as Pseudomonas aeruginosa, Klebsiella pneumoniae and
Salmonella enterica [78–81]. In addition, the pmrAB TCS has been shown to regulate genes involved in
lipopolysaccharide modification [80,82]. Colistin resistance in A. baumannii is conferred by mutations
in pmrAB that lead to overexpression of the response regulator PmrA and/or the sensor kinase PmrB,
which suggests that differential expression of members of the pmrAB regulon are responsible for the
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resistant phenotype. However, the complete regulon controlled by PmrAB in A. baumannii has not
been investigated in detail.
Modifications of lipopolysaccharides (LPS) in the cell envelope are recognized mechanisms that
cause polymyxin resistance. For instance, in Salmonella, addition of 4-amino-4-deoxy-L-arabinose
or phosphoethanolamine to lipid A reduces the overall negative surface charge of the bacterial
cell and thereby decreases electrostatic interactions with cationic peptides [83–87]. As well,
changes in PmrB levels in colistin-resistant A. baumannii strains led to modification of lipid A with
phosphoethanolamine [65,88]. Conversely, complete loss of LPS increases colistin resistance, but it
is yet to be determined whether pmrAB is directly involved in this resistance [89]. Slightly acidic
pH (pH 5.5), ferric iron (Fe3+) or low magnesium levels could be the signals sensed by the sensor
kinase PmrB, as these environmental conditions increase the MIC for colistin [76,88,90]. Acquiring
colistin resistance through mutations in pmrAB can lead to decreased bacterial fitness in in vitro growth
experiments and in in vivo infection models [91–94]. For example, colistin-resistant clinical isolates
showed impaired virulence in a rat model of pneumonia [95] and in intraperitoneally infected mice
that were attributed to mutations in PmrAB [91]. In addition to conferring resistance to polymyxins,
PmrAB might control the expression of a set of virulence factors or the changes of lipid A modification
could directly account for the altered virulence phenotypes [88].
3. Regulation of Iron and Zinc Acquisition
The acquisition of metals, such as iron, zinc or manganese, is essential for all living organisms,
because they are key to many important physiological processes. Depleting bacterial pathogens
of essential metals is a host strategy to limit pathogen expansion—a strategy termed nutritional
immunity [96–98]. The host expresses a set of proteins, such as haemoglobin, transferrin, lactoferrin
or calprotectin that sequester iron, zinc and manganese making them less available for an invading
pathogen. To subvert the host defence mechanisms, bacterial pathogens have evolved strategies to
counter metal limitation by expressing efficient metal uptake systems and secrete molecules that bind
metals in the environment and that may subsequently be taken up again. In A. baumannii, the regulation
of the systems controlling iron and zinc acquisition have been studied and are reviewed below.
3.1. Fur—the Ferric Uptake Regulator
Iron is required for many cellular processes, for instance for DNA precursor synthesis or as
cofactors in redox enzymes. To compete for iron with the host, bacteria have evolved intricate iron
acquisition mechanisms. One mechanism to secure free iron is to secrete iron-chelating molecules
(siderophores) which may later be taken up again from the environment or to scavenge iron bound to
host transferrin and lactoferrin [99]. In bacteria, siderophore-encoding genes are often located in gene
clusters. In A. baumannii, genomic comparisons have identified five siderophore gene clusters, however,
A. baumannii isolates may possess different siderophore repertoires [66,100]. One well-characterized
siderophore is termed acinetobactin [99,101], which is structurally and functionally related to
anguibactin from Vibrio anguillarum [102]. Acinetobactin-facilitated iron acquisition has been reported
to be an important virulence factor in several A. baumannii infection models [103]. Upon inactivation
of the acinetobactin-mediated iron uptake and utilization system, reduced apoptosis in A. baumannii
infected alveolar epithelial cells A549 was reported and decreased virulence in Galleria mellonella
larvae infections and a mouse sepsis model was observed [103]. In many Gram-negative bacteria
including A. baumannii, iron acquisition-related genes are controlled by the ferric uptake regulator
(Fur). The Fur protein is a transcriptional repressor that binds a 19 bp AT-rich consensus sequence,
called the “Fur box” when containing ferrous iron (Fe2+) [66], and the Fur amino acid sequence in
A. baumannii is 63% identical with the well-studied Fur protein in E. coli [104]. In response to iron
limitation in vitro, 1207 A. baumannii ATCC17978 genes showed differential gene expression [66].
The siderophore clusters 1 and 2 and the acinetobactin cluster were strongly upregulated clusters
and they possess candidate Fur-binding sites suggesting that Fur is directly involved in expression of
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siderophores. A second Fur-like protein (ABEYE1889) has been discovered in A. baumannii, however,
it appears to be restricted to the A. baumannii AYE strain so far [66]. Functional characterization of
ABEYE1889 is lacking, however, it might add complexity to the control of iron homeostasis. Fur has
also been suggested to be involved in regulating the tonB-exbB-exbD system which is energizing
transport processes across the outer membrane, for example of iron-siderophore complexes [105,106].
In A. baumannii ATCC19606, three tonB genes have been identified and only the expression of tonB3
responds to iron levels and is predicted to be Fur-regulated. The tonB-exbB-exbD might play a role in
A. baumannii infections, as TonB proteins were required for full virulence in Galleria mellonella larvae
infections [105].
3.2. Zur—the Zinc Uptake Regulator
In bacteria, zinc is required for the action of metalloproteins, such as metalloproteases [107].
In response to zinc limitation, A. baumannii upregulates an inner membrane ABC transporter encoded
by the znuABC genes to increase zinc uptake [67]. The regulation of zinc-associated genes is controlled
by Zur (zinc uptake regulator), a zinc-binding regulatory protein and a member of the Fur protein
family [67,68]. Like Fur, Zur functions as a transcriptional repressor binding to DNA at 19 bp consensus
sequence in a zinc-dependent manner. De-repression of Zur-controlled genes occurs in zinc-depleted
conditions, when the Zur apoprotein can no longer bind to DNA. In an A. baumannii transcriptomic
study, deletion of zur resulted in differential expression of 144 genes, however, it is unclear how many
are directly regulated by Zur. Among the differentially expressed genes were 11 (seven upregulated
and four downregulated in the zur mutant strain) transcription factors suggesting significant cross-talk
with other regulatory systems. Zinc acquisition is crucial for A. baumannii virulence. In a mouse
pneumonia model, Zur was shown to be required for dissemination to the liver and this effect was
abolished in calprotectin-deficient mice [67,68].
Considered together, this illustrates the importance of precise regulation of metal acquisition
systems and homeostasis for A. baumannii during infection. Thus, antimicrobials targeting these
systems might prove to be particularly promising. For instance, the iron mimetic gallium nitrate
(Ga(NO3)) inhibited growth of 58 A. baumannii strains in defined medium and in human serum and
increased the survival rate of A. baumannii-infected Galleria mellonella larvae [108]. In addition, gallium
nitrate dispersed A. baumannii biofilms produced in complement-free human serum [109]. Gallium
competes with iron for bacterial iron acquisition systems and iron-binding proteins and may inhibit
their function, because unlike Fe3+, Ga3+ cannot be reduced under physiological conditions [110,111].
Thus, gallium-based compounds may be included in effective antibacterial treatment strategies.
4. Biofilm Formation and Quorum Sensing
Biofilm formation by pathogenic bacteria is a challenge in healthcare because biofilms make
bacteria more resistant to antibiotics, reduce the effectiveness of decontamination efforts, and increase
persistence of bacteria on indwelling devices. Multiple regulatory pathways have been implicated
in biofilm formation by A. baumannii, including the surprising finding that biofilm formation on
polystyrene surfaces requires BfmR (described above), but not BfmS [54]. Several studies have linked
biofilm formation by A. baumannii to quorum sensing. A. baumannii encodes abaI and abaR, homologs
of Vibrio’s archetypal quorum sensing genes luxI and luxR, respectively [112,113]. The enzyme AbaI
produces N-acyl-homoserine lactone (AHL), a diffusible molecule that functions as an autoinducer by
binding the AHL-responsive transcription factor AbaR [112]. Deleting abaI reduces biofilm formation
in A. baumannii [69,112]. Surveys of clinical isolates indicate that about half can form biofilms in
laboratory conditions, yet only a subset of biofilm-forming strains produce AHL [69,70]. Bacteria
transition from free-living to biofilm physiology by producing adherent proteins and extracellular
matrices that reinforce biofilm structures; for example, in the well-characterized model Pseudomonas,
genes for biofilm formation are regulated by quorum sensing systems [114]. Thus, it is reasonable
to hypothesize that AbaR activates biofilm gene expression in A. baumannii when AHLs rise to
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autoinducing concentrations. Curiously, some A. baumannii strains only encode an orphan abaI that
appears to lack the cognate response regulator abaR [70]. This is counter to genome-wide analyses
which indicate that luxR homologs usually outnumber luxI homologs [115], and that some species
have a luxR homolog for sensing AHL signals but lack luxI and so do not contribute to signalling [116].
Could the unusual A. baumannii strains represent a special case of organisms that generate AHLs but
do not sense them? In other words, might these A. baumannii strains generate AHLs for interspecies
signalling to manipulate gene expression in neighbouring strains? Alternatively, in the absence of
AbaR, AbaI may cross-talk with other quorum sensing systems in the same cell.
5. Other Regulatory Proteins
5.1. AtfA
The acidic transcription factor A (AtfA) in Acinetobacter spp. is a small protein (67–68 amino acids)
that was first functionally described in A. baylyi ADP1 [71]. The gene has been unfortunately termed
atfA, which is a name shared with the wax ester synthase/acyl-CoA:diacylglycerol acetyltransferase
enzyme in A. baylyi ADP1 [117,118]. Deletion of atfA transcription factor resulted in gene expression
changes of over 500 genes including several virulence-associated traits. Massive phenotypic changes
were observed in atfA deletions in A. baylyi ADP1 and A. baumannii ATCC19606, including cell
enlargement, loss of biofilm formation, reduced twitching motility and increased susceptibility to
antibiotics and ethanol. Differences in response to ethanol might alter the expression of ethanol-induced
virulence factors, such as phospholipase C [119]. Mechanistically, AtfA does not seem to be a classical
transcription factor, but was shown to bind directly to RNA polymerase in a 1:1 ratio. This displaced
DNA from RNA polymerase core complexes, but did not displace DNA from the holoenzyme
containing a sigma factor [71]. The location of atfA adjacent to the gene encoding the major sigma
factor 70 could be significant for the co-regulation of this transcription factor with core transcriptional
machinery. Thus, the extent of gene expression and phenotypic changes and the mechanistic insight
into AtfA action indicate that AtfA is a global regulator. AtfA is conserved in the gamma-proteobacteria
Moraxella, Pseudomonas, Legionella, Vibrio and Acinetobacter, but absent in Enterobacteriaceae [71].
5.2. Nucleoid-Associated Protein H-NS
Nucleoid-associated proteins and DNA supercoiling shape the bacterial nucleoid [120,121].
By virtue of their high abundance, binding across the bacterial chromosome, and the ability to constrain
regions of DNA supercoiling, nucleoid-associated proteins affect the expression of many hundreds of
genes in model organisms like E. coli and Salmonella [122]. Acinetobacter sp. encode an H-NS homolog
that can complement an E. coli hns deletion mutant [72]. Deletion of the A. baumannii ATCC 17978
hns homolog (A1S_0268) caused a hyper-motile phenotype along with enhanced adherence to human
pneumocytes and enhanced virulence in a nematode infection assay [73]. Ninety-one genes were
upregulated in the hns mutant, including the genes encoding the virulence-associated adhesin ata
(A1S_1032), a type-VI secretion system (A1S_1292-1311), and genes for type I pili. The most highly
upregulated genes had AT-rich promoter regions, consistent with H-NS affinity for AT-rich DNA in
the well-studied E. coli and Salmonella systems. A role for A. baumannii H-NS in xenogeneic silencing
was reported as several genomic islands were found to be repressed by H-NS [73]. To our knowledge,
gene regulatory effects of DNA supercoiling have not been studied in Acinetobacter.
6. Global Studies Identifying Important Regulators
Random global mutagenesis studies in bacteria have been instrumental to studying gene function.
About a decade ago, classical genetic screenings using mobile genetic elements, such as transposons,
have been paired with next-generation sequencing to allow high throughput identification and
quantification of transposon insertions to assess the contribution of transposon-disrupted genes
to bacterial fitness [123,124]. Among many other studies, transposon-insertion sequencing allowed
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the identification of Salmonella genes involved in colonization of farm animals [125], revealed novel
genotype–phenotype relationships in Streptococcus pneumoniae [126] and detected essential genes
in Rhizobiaceae [127]. Transposon-insertion sequencing in a A. baumannii ATCC17978 pneumonia
model identified seven regulatory proteins that contribute to lung persistence (Table 2, [128]). Among
them are the aforementioned response regulators GacA and BfmR, as well as the BfmS sensor kinase.
Integration host factor (IHF), a homolog of the E. coli nucleoid-associated protein IHF, was shown to
be required for virulence, however, H-NS was not. Acinetobacter junii and E. coli IHF bind similar DNA
sites and both can repress transcription [129], but little else is known about Acinetobacter IHF function.
Other predicted regulators required for persistence in the mouse lung are two LysR-type regulators
(A1S_2122, A1S_2537, Table 2) and the putative high affinity phosphate uptake regulator phoU (Table 2),
none of which have been studied in detail. Prediction of gene function suggested involvement of
A1S_2122 in methionine synthesis [128]. The gene encoding A1S_2537 lies downstream of a number of
genes predicted to mediate sulfate transport. Thus, both regulators might be involved in metabolism
of sulfur-containing molecules. More recently, Gebhardt et al. performed a transposon-screen in
A. baumannii strain AB5075 showing that virulence and resistance genes appear to be co-regulated
in response to antibiotic and environmental stress [130]. In the same study, 17 (putative) regulatory
proteins were identified that were required for growth in Galleria mellonella larvae (Table 3), suggesting
that strains possessing increased resistance to antibiotics might simultaneously possess improved
virulence properties.
Table 2. Regulators required for persistence in the mouse lung (ATCC17978; [128]).
Gene
Name
Gene Identifier
Product
ATCC17978 ATCC17978-mff AB5075-UW
gacA A1S_0236 ACX60_RS16900 ABUW_RS17720 Two-component response regulator
phoU A1S_0256 ACX60_RS16800 ABUW_RS17620 High affinity phosphate uptaketranscriptional repressor
ihfA A1S_0603 ACX60_RS15110 ABUW_RS15930 Integration host factor subunit alpha
bfmR A1S_0748 ACX60_RS14635 ABUW_RS15450 Two-component response regulator
bfmS A1S_0749 ACX60_RS14630 ABUW_RS15445 Two-component sensor histidine kinase
- A1S_2122 ACX60_RS06950 ABUW_RS07810 LysR family transcriptional regulator
- A1S_2537 ACX60_RS04880 ABUW_RS04985 LysR family transcriptional regulator
Table 3. Regulators required for growth in Galleria mellonella (AB5075; [130]).
Gene
Name
Gene Identifier
Product
ATCC17978 ATCC17978-mff AB5075-UW
- A1S_2082 ACX60_RS11775 ABUW_RS08030 TetR family transcriptional regulator
- A1S_2064 ACX60_RS07270 ABUW_RS08145 LysR family transcriptional regulator
- A1S_2042 ACX60_RS07365 ABUW_RS08240 TetR family transcriptional regulator
- A1S_1958 ACX60_RS08015 ABUW_RS08550 AsnC family transcriptional regulator
- A1S_1948 ACX60_RS08070 ABUW_RS08610 MarR family transcriptional regulator
- A1S_1874 ACX60_RS08460 ABUW_RS09000 LysR family transcriptional regulator
- not present not present ABUW_RS09560 LysR family transcriptional regulator
- not present not present ABUW_RS10070 Fur family transcriptional regulator
alkR A1S_1640 ACX60_RS09755 ABUW_RS10675 AraC family transcriptional regulator
- A1S_1578 ACX60_RS10205 ABUW_RS10870 AraC family transcriptional regulator
arsR A1S_1453 ACX60_RS10865 ABUW_RS11530 ArsR family transcriptional regulator
- A1S_1350 ACX60_RS11395 ABUW_RS12250 TetR family transcriptional regulator
- A1S_1330 ACX60_RS11505 ABUW_RS12365 AraC family transcriptional regulator
soxR A1S_1320 ACX60_RS11550 ABUW_RS12410 Redox-sensitive transcriptional activator
- A1S_0768 ACX60_RS14535 ABUW_RS15350 LysR family transcriptional regulator
bfmS A1S_0749 ACX60_RS14630 ABUW_RS15445 Two-component sensor histidine kinase
- A1S_0621 ACX60_RS15010 ABUW_RS15830 Putative two-component response regulator
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The large number of important, yet functionally uncharacterized virulence gene regulators
(Tables 2 and 3) highlight the need to study their regulons to obtain a more complete picture of the
regulatory networks governing virulence gene expression. These approaches need to be extended
to study antibiotic resistance genes and their regulation to reveal novel potential target for drug
intervention. Novel global genomic approaches, such as CRISPR interference (CRISPRi), promise to
accelerate the understanding of gene function and regulation [124,131].
7. Do Small Regulatory RNAs Have a Role in A. baumannii Virulence or Antibiotic Resistance?
Small RNAs (sRNAs) are now fully established as a class of gene regulators of various cellular
processes in bacteria [132–135]. Best understood are expression patterns and regulatory mechanisms
employed by small non-coding RNAs in Enterobacteriaceae such as E. coli and Salmonella [136–140].
So far, we lack information as to whether sRNA-mediated regulation in A. baumannii is analogous to
these well-studied systems. Bioinformatic analysis of the A. baumannii ATCC17978 genome identified
31 putative small RNA candidates, of which three were confirmed by Northern blotting using strain
ATCC15308 [141]. In the multidrug resistant A. baumannii strain AB5075, 78 small RNAs were identified
using RNA-sequencing [142]. However, we lack insight as to whether these sRNA candidates possess
any physiological function or how they might function mechanistically.
In Enterobacteriaceae, one function of the RNA-binding protein Hfq is to facilitate the
interaction of sRNA and their cognate mRNA targets [143]. Yet in Acinetobacter’s closer relative,
Pseudomonas aeruginosa, the role of Hfq in sRNA-mediated regulation is less clear and does not seem
to follow the same model as in Enterobacteriaceae [144,145]. In Acinetobacter spp., Hfq has only been
studied in the avirulent A. baylyi. Hfq possesses an unusually long, glycine-rich C-terminus, which
is a unique feature of Acinetobacter spp. Hfq. This may impact how and where RNAs bind to Hfq,
as well as how Hfq interacts with other cellular players [146]. In other bacterial pathogens, deletions in
RNA binding proteins such as Hfq or CsrA often results in avirulent phenotypes [147–150], however,
the role of Hfq in A. baumannii virulence or antibiotic resistance remains unknown. Only the sRNA Aar
has been studied as a regulatory RNA in A. baylyi. Aar, which is conserved in A. baumannii [142,151],
was suggested to play a role in amino acid metabolism of A. baylyi, but mechanistic details remain
unknown [151]. Several Hfq-dependent sRNAs have been described to control iron homeostasis
in other Gram-negative bacteria [152,153] and there might be a connection of sRNA-mediated
gene regulation and iron homeostasis in A. baumannii, because a proteomic study showed that
A. baumannii Hfq protein levels decreased in iron-limiting conditions [154]. Moreover, Hfq protein
and Hfq-dependent sRNAs have been identified to play a role in antibiotic resistance, as small RNAs
control the expression of many cellular targets of antibiotic action [155–157]. In Enterobacteriaceae,
outer membrane homeostasis of major porins OmpA, OmpC, OmpD and OmpF is controlled by
the concerted action of several small RNAs [158–163]. In addition, the outer membrane component
of the RND superfamily multidrug transporter TolC is regulated by the sRNA SdsR in E. coli [164].
Considering the prominent role of OmpA in A. baumannii virulence and drug resistance [165–167],
it will be interesting to investigate whether a similar sRNA-mediated control of A. baumannii OmpA
and other outer membrane proteins exists.
Considered together, it will be important to elucidate the regulons and regulatory
mechanisms of sRNA along with identification and characterisation of RNA binding proteins in
Acinetobacter—especially during infection and upon exposure to antibiotics.
8. Conclusions and Outlook
Bacterial pathogens must adapt quickly to changing environments, for example, during host
entry or in harsh environmental conditions, and modulate their gene expression programs accordingly.
This is achieved by multiple regulatory systems that govern correct spatiotemporal gene expression.
In the bacterial pathogen A. baumannii, an increasing number of virulence genes have been identified
over the last few years, however, their gene regulation remains largely unknown. So far, very few
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regulons have been defined and we lack data for all A. baumannii transcription factors whether
regulatory effects are direct or indirect. This highlights the need to use and combine global
approaches such as DNA binding studies using chromatin-immunoprecipitation (ChIP) sequencing,
transposon-insertion sequencing, CRISPR interference and RNA-sequencing to define direct and
indirect effects of regulatory proteins in A. baumannii and to identify regulators that control virulence
gene expression and antibiotic resistance. In addition, the extent and mechanisms of RNA-mediated
gene regulation remain completely unknown. To improve the ability to study gene regulation in
detail, the range of basic molecular tools, such as reporter plasmids, needs to be expanded, however,
this can be hampered by the multidrug resistant genotypes of clinical isolates and the lack of detailed
knowledge about restriction modification systems in A. baumannii. Moreover, to make generalizing
statements about A. baumannii virulence and antibiotic resistance as well as their genetic regulation
is complicated by the significant strain-to-strain differences. Thus, we require multiple efforts to
understand how genes are regulated in this important opportunistic pathogen that could inform the
development of knowledge-based interventions.
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